Cleared Traditional

K090610 - HOSPIRA VITAL SIGNS WIRELESS MONITORING SYSTEM

K090610 is an FDA 510(k) clearance for HOSPIRA VITAL SIGNS WIRELESS MONITORING..., manufactured by Hospira, Inc.. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 7-day FDA review.

K090610 · Hospira, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 2009
Decision
7d
Days
Class 2
Risk

K090610 is an FDA 510(k) clearance for the HOSPIRA VITAL SIGNS WIRELESS MONITORING SYSTEM. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Hospira, Inc. (Lake Forest, US). The FDA issued a Cleared decision on March 13, 2009 after a review of 7 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K090610

510(k) Number K090610 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2009
Decision Date March 13, 2009
Days to Decision 7 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 125d · This submission: 7d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
NED DEVINE

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 187
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K090610.
MEDAPPS 2.0 REMOTE PATIENT MONITORING SYSTEM
K083862 · Medapps, Inc. · Jun 2009
RTX 3371
K090886 · Tunstall Healthcare · Apr 2009
ELECTRONIC HOUSE CALL
K090801 · Express MD Solutions, LLC · Apr 2009
HEALTH MANAGER, VERSION 1.1
K081499 · Biocomfort Diagnostics GmbH & Co. KG · Jan 2009
FORA TELEHEALTH SYSTEM
K083046 · Taidoc Technology Corporation · Jan 2009
CONFIDANT, MODEL 2.6
K083331 · Confidant, Inc. · Jan 2009
K090610 · HOSPIRA VITAL SIGNS WIRELESS MONITORING SYSTEM
Download PDF FDA Summary Hospira, Inc.